Pacemaker implantation after tricuspid valve replacement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the management of pacemaker implantation in patients who have undergone transcatheter tricuspid valve replacement (TTVR), a procedure associated with a high risk of complete atrioventricular block. The goal is to determine the optimal therapeutic approach for these patients, as the best practices for pacemaker management following TTVR are currently unclear. By observing patients post-TTVR, the study aims to gather data that could inform future guidelines and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Transcatheter Tricuspid Valve Replacement

Exclusion Criteria:

* no defined exclusion criteria

Where it's running

• Deutsches Herzzentrum München
  München, Bavaria, Germany Recruiting

Study contacts

• Study coordinator: Carsten Lennerz, PD Dr. med.
• Email: lennerz@dhm.mhn.de
• Phone: 0049 89 1218 4401

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• What happens to the tricuspid valve in atrial fibrillation patients without strong valve leakage

  This study looks at how the tricuspid valve changes over a year in people with atrial fibrillation who don’t have significant valve leakage, using 3D heart imaging.

  Recruiting Centro Cardiologico Monzino · Milan, Milan · NCT07617974

• Early rhythm control in atrial fibrillation with tricuspid regurgitation

  This study tests whether starting rhythm control early in people with atrial fibrillation and tricuspid regurgitation can improve outcomes compared with usual care.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07607093

• TriClip System post-market safety and performance in real-world tricuspid regurgitation patients

  This study tests whether the TriClip System is safe and works well for adults with tricuspid regurgitation in routine care settings.

  Recruiting at 14 sites Abbott Medical Devices · Phoenix, Arizona and 13 other locations · NCT07586995

• Topaz TTVR vs EVOQUE TTVR for severe tricuspid regurgitation

  A study tests whether the TRiCares Topaz transcatheter tricuspid valve replacement system works safely and effectively for adults with severe tricuspid regurgitation who are candidates for valve replacement.

  Recruiting TRiCares · Atlanta, Georgia · NCT07528326

• Robotic transjugular tricuspid valve replacement using the Lux-valve plus system.

  This trial tests a robotic transjugular procedure using the Lux-valve plus to replace the tricuspid valve in adults with severe symptomatic tricuspid regurgitation who are high risk for open surgery.

  Recruiting Prince of Wales Hospital, Shatin, Hong Kong · Shatin · NCT07516145

• LuX-Valve Plus vs EVOQUE for transvenous tricuspid replacement in severe tricuspid regurgitation

  This trial tests whether the LuX-Valve Plus system can safely and effectively treat adults with severe tricuspid regurgitation compared to the EVOQUE device.

  Recruiting at 7 sites Jenscare Innovation Inc. · Naples, Florida and 6 other locations · NCT07454980

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.